ArticleHealth economics review2025
Understanding women's preferences for long-acting reversible contraceptives in Gondar, Ethiopia: a discrete choice experiment.
Article in Health economics review, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIn Ethiopia, limited use of long-acting reversible contraceptives (LARCs) contributes to unintended pregnancies, unsafe abortions, and preventable maternal deaths. Despite their proven effectiveness, LARCs remain underutilized. Evidence on women's preferences and willingness to pay (WTP) is scarce. This study examined women's stated preferences, WTP, and trade-offs regarding LARC use in Gondar.
methodsAn institution-based cross-sectional study was conducted among 344 contraceptive users, generating 8,256 observations. A discrete choice experiment (DCE) with 24 choice tasks, divided into two blocks, was employed. Each task presented two unlabeled alternatives defined by six key attributes, identified through literature review and expert consultation. Data were analyzed using mixed logit models to estimate preference strength and WTP based on model coefficients.
resultsThe analysis revealed that provider type significantly influenced women's preferences. Women showed the highest WTP for LARCs provided by midwives [528 ETB (10.15 USD)], compared to services offered by doctors [285 ETB (5.48 USD)] and health officers [215 ETB (4.13 USD)]. Preferences were also shaped by side-effect profiles: methods associated with slight weight gain [155 ETB (2.98 USD)], high effectiveness [80 ETB (1.54 USD)], and absence of bleeding [74 ETB (1.43 USD)] were positively valued. Conversely, heavy menstrual bleeding led to the largest reduction in WTP [-688 ETB (-13.24 USD)], indicating a significant barrier to LARC uptake. Longer-acting methods also reduced WTP [-139 ETB (-2.68 USD)], possibly reflecting concerns about long-term commitment or side effects. Cost sensitivity was evident, as increases of 100 ETB (1.92 USD) or 500 ETB (9.92 USD) further reduced uptake likelihood.
conclusionWomen's preferences for LARCs are influenced by provider type, side effects, and cost. Enhancing LARC services by prioritizing midwife-led delivery, addressing side effects such as heavy menstrual bleeding, and considering women's WTP can increase uptake. These findings highlight the need for affordable, user-centered contraceptive services in Ethiopia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.